Pure Global

Citice Leptospira IgG/IgM antibody rapid screening reagent - Taiwan Registration 3b3e4ab9ade4f58817927d0aaa8802bd

Access comprehensive regulatory information for Citice Leptospira IgG/IgM antibody rapid screening reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 3b3e4ab9ade4f58817927d0aaa8802bd and manufactured by CTK BIOTECH, INC.. The authorized representative in Taiwan is Ariel Health Inc.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
3b3e4ab9ade4f58817927d0aaa8802bd
Registration Details
Taiwan FDA Registration: 3b3e4ab9ade4f58817927d0aaa8802bd
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Citice Leptospira IgG/IgM antibody rapid screening reagent
TW: ่ฅฟๅธๅ…‹ ้‰ค็ซฏ่žบๆ—‹้ซ”IgG/IgMๆŠ—้ซ”ๅฟซ้€Ÿ็ฏฉๆชข่ฉฆๅŠ‘
Risk Class 1
Cancelled

Registration Details

3b3e4ab9ade4f58817927d0aaa8802bd

DHA04400865007

Company Information

United States

Product Details

Limited to the first level identification range of the medical device management measures "Leptospira sera reagent (C.3350)".

C Immunology and microbiology

C.3350 ้‰ค็ซฏ่žบๆ—‹่Œๅฑฌ่ก€ๆธ…่ฉฆๅŠ‘

import

Dates and Status

Mar 26, 2010

Mar 26, 2015

Apr 25, 2018

Cancellation Information

Logged out

่‡ช่กŒ้ตๅ…ฅ